KARX Karbon-X Corp.
Perfumes, Cosmetics & Other Toilet Preparations · OTC · SEC CIK 1729637 · Fiscal year ends 05/31
Financial factors as of 2025-08-31 (2026Q1), TTM = sum of the last four quarters
Growth
TTM revenue YoY7,124.9%
TTM net income YoY-160.1%
TTM EPS YoY-154.7%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin2.8%
Operating margin-21.2%
Net margin-21.5%
FCF margin—
EBITDA margin-21.0%
Returns
ROE-922.5%
ROA-155.1%
ROIC (approx.)—
Asset turnover7.21x
Leverage & solvency
Liabilities / assets118.1%
Debt / equity—
Current ratio0.78x
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.93x
Accruals ratio-11.2%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20262026-05-31 | FY20252025-05-31 |
|---|---|---|
| Income statement | ||
| Revenue | $55.86M | $3.16M |
| Cost of revenue | $55.00M | $2.36M |
| Gross profit | $859,842 | $801,467 |
| Operating income | -$11.07M | -$6.65M |
| Interest expense | $3.32M | $339,204 |
| Pretax income | -$13.59M | -$7.05M |
| Income tax | $0 | $0 |
| Net income | -$13.59M | -$7.05M |
| EBITDA | -$10.87M | -$6.64M |
| EPS (basic) | -0.16 | -0.08 |
| EPS (diluted) | -0.16 | -0.08 |
| Weighted avg. shares (diluted) | 86.72M | 83.56M |
| Balance sheet | ||
| Cash & equivalents | $1.16M | $704,346 |
| Receivables | $634,291 | $1,782 |
| Inventory | $649,973 | $99,644 |
| Current assets | $6.06M | $5.79M |
| PP&E, net | $8,004 | $6,132 |
| Intangibles | $644,345 | $0 |
| Total assets | $9.62M | $6.78M |
| Current liabilities | $10.10M | $7.69M |
| Short-term debt | — | $0 |
| Long-term debt | $4.88M | $0 |
| Total debt | $4.88M | $0 |
| Total liabilities | $15.60M | $8.15M |
| Shareholders' equity | -$5.98M | -$1.37M |
| Net debt | $3.73M | -$704,346 |
| Shares outstanding | 94.89M | 81.99M |
| Cash flow statement | ||
| Operating cash flow | -$7.86M | -$6.50M |
| Capital expenditure | $4,341 | $2,543 |
| Free cash flow | -$7.87M | -$6.50M |
| Investing cash flow | -$2.43M | -$2,543 |
| Financing cash flow | $10.50M | $4.56M |
| Depreciation & amortization | $197,804 | $3,225 |
| Stock-based compensation | $1.26M | $627,495 |
Free plan shows the latest 2 periods; Pro shows all 8 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.